Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-16-155280
Filing Date
2016-12-14
Accepted
2016-12-14 21:04:05
Documents
1
Period of Report
2016-12-12

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3961
  Complete submission text file 0001209191-16-155280.txt   5379
Mailing Address 740 HEINZ AVENUE BERKELEY CA 94710
Business Address 740 HEINZ AVENUE BERKELEY CA 94710 510-848-4400
ADURO BIOTECH, INC. (Issuer) CIK: 0001435049 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ADURO BIOTECH, INC. 740 HEINZ AVENUE BERKELEY CA 94710
Business Address
Brockstedt Dirk G. (Reporting) CIK: 0001635616 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37345 | Film No.: 162052196